How Will the Global Downturn Impact Your Portfolio?
Investors should consider the interconnections between markets.
|Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.|
For the second year running, we applied Morningstar's Revenue Exposure by Region data to our family of country indexes, which span 48 developed and emerging equity markets. The aim is to reflect geographic exposure, based not on where companies are located but where they do business. With the coronavirus pandemic ravaging the global economy, investors are both examining their portfolios for vulnerabilities and considering opportunities. Linkages between markets are important to consider.
An Interconnected World
According to the map below, thirty-one of Morningstar's 48 country indexes source more than one third of their revenues from outside their home markets, using estimated data from corporate filings. That includes the United States and Japan, both of which saw an increase in foreign-sourced revenue compared with last year's study. Look at the global players that dominate the Morningstar US Market Index--Microsoft (MSFT), Apple (AAPL), and Google parent Alphabet (GOOG)--and the two largest companies in Japan's market, Toyota and Sony, and it's clear why.
China, by contrast, is a domestically focused market. Exports may represent a significant share of its economy, but China's equity market, dominated by companies like Alibaba and Tencent, is inward-looking.
China is typical of emerging markets with large populations. Pakistan, Indonesia, the Philippines, Turkey, and Brazil are also quite self-contained. India is an exception; its market has a large slug of global technology players.
Meanwhile, countries like Germany, South Korea, Taiwan, and Singapore may have responded well to the global pandemic, but their markets are highly exposed to the global economy.
European markets are by far the most global. Ireland, the Netherlands, and Switzerland top the list of the most outwardly oriented. Other markets with significant revenue sourced abroad include Canada, South Africa, and Australia.
The U.S. is critical to the revenues of markets around the world. Ireland is most exposed to the U.S. economy at roughly 35% of revenue. Canada, Switzerland, Denmark, Taiwan, the United Kingdom, the Netherlands, Israel, and Germany all derive 20% or more of their revenue from the U.S. Mexico's market, surprisingly, is more closely linked to Latin America than to the U.S.
China is a key source of revenue for many markets, especially Singapore, Taiwan, South Korea, and Hong Kong. The U.K. is the non-Asian market most dependent on revenue from emerging Asia, thanks to index constituents like HSBC. Switzerland is heavily dependent on China, driven by companies like Nestle and Roche, and so is France, with Sanofi, LVHM, Total, and L'Oreal. The U.S. has an estimated 7.3% revenue exposure to China, far higher than the other way around.
It's no surprise that eurozone countries are interdependent. But investors should also note that European markets outside the eurozone--in Scandinavia and Switzerland--are heavily exposed to the region. The U.K. sources just 12% of revenue from the eurozone. It is tied more closely to Asia and the U.S. than it is to Europe, diminishing the impact of Brexit for investors. South Africa is the non-European country with the most eurozone exposure; that's thanks to top index constituent Naspers, a global Internet player.
Other interlinkages abound. The Spanish market derives nearly one fifth of its revenues from Latin America. New Zealand is dependent on Australia for 15% of its market's revenue, while Portugal relies on Poland to roughly the same degree. Ireland generates 18% of revenue from the U.K.
Clearly, national equity markets are not as national as many investors assume. This will influence how a global economic downturn impacts different markets.
Disclosure: Morningstar, Inc. licenses indexes to financial institutions as the tracking indexes for investable products, such as exchange-traded funds, sponsored by the financial institution. The license fee for such use is paid by the sponsoring financial institution based mainly on the total assets of the investable product. Please click here for a list of investable products that track or have tracked a Morningstar index. Neither Morningstar, Inc. nor its investment management division markets, sells, or makes any representations regarding the advisability of investing in any investable product that tracks a Morningstar index.
Dan Lefkovitz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.